AR

Ancymol Resily

Director Director DIN 07066954
DIN 07066954 First appointment Oct 2014 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2014
Shareholding value Locked Premium profile

About Ancymol Resily

Data last updated:

Ancymol Resily has 11 years in corporate governance. Formerly with 1 company, such as Raihan Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 07066954
Primary Designation Director
First Appointment 12 Oct 2014
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Raihan Healthcare Private Limited U85194KL2013PTC035127
Director12 Oct 20142013Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Raihan Healthcare Private Limited
Premium access

Shareholding and investment profile for Ancymol Resily

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ancymol Resily

Ancymol Resily has 11 years in corporate governance. Formerly with 1 company, such as Raihan Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Ancymol Resily is associated with 0 companies as a director.

Ancymol Resily has expertise in Healthcare.

Ancymol Resily has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available